本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MBX Biosciences

61.08
+1.592.67%
成交量:65.26萬
成交額:3,921.80萬
市值:29.42億
市盈率:-25.39
高:61.20
開:58.79
低:58.39
收:59.49
52周最高:72.64
52周最低:9.64
股本:4,816.01萬
流通股本:2,762.99萬
量比:1.95
換手率:2.36%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
淨資產收益率:-33.17%
總資產收益率:-22.08%
市淨率:7.18
市盈率(LYR):-25.64

資料載入中...

2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/22

重要事件披露

Form 8-K - Current report
2026/01/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities